FRAZIER ALAN D

CIK 00010185347 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001018534

Recent Transactions

50 trades

Other
ANAPTYSBIO, INC$ANAB
Common Stock
2018-05-11−1,372,000→ 973,612 total
Other
ANAPTYSBIO, INC$ANAB
Common Stock
2018-05-11−1,372,000→ 973,612 total
Exercise of In-Money
ANAPTYSBIO, INC$ANAB
Warrants
2017-02-02−117,235→ 0 total
Exercise of In-Money
ANAPTYSBIO, INC$ANAB
Common Stock
2017-02-02$4.55/sh+117,235→ 2,345,612 total
Exercise of In-Money
ANAPTYSBIO, INC$ANAB
Common Stock
2017-02-02$4.55/sh+117,235→ 2,345,612 total
Exercise of In-Money
ANAPTYSBIO, INC$ANAB
Warrants
2017-02-02−117,235→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Series D Preferred Stock
2017-01-31−209,095→ 0 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31$15.00/sh+88,709→ 88,709 total
Conversion
ANAPTYSBIO, INC$ANAB
Series B Preferred Stock
2017-01-31−1,428,571→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Series C Preferred Stock
2017-01-31−604,055→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Series D Preferred Stock
2017-01-31−733,740→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Series B Preferred Stock
2017-01-31−1,428,571→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Series D Preferred Stock
2017-01-31−733,740→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+733,740→ 733,740 total
Conversion
ANAPTYSBIO, INC$ANAB
Series D Preferred Stock
2017-01-31−209,095→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Series C-1 Preferred Stock
2017-01-31−195,751→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+1,428,571→ 1,428,571 total
Conversion
ANAPTYSBIO, INC$ANAB
Series C Preferred Stock
2017-01-31−604,055→ 0 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31$15.00/sh+311,291→ 311,291 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+1,428,571→ 1,428,571 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+195,751→ 195,751 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31$15.00/sh+88,709→ 88,709 total
Conversion
ANAPTYSBIO, INC$ANAB
Series C-1 Preferred Stock
2017-01-31−195,751→ 0 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+604,055→ 604,055 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+733,740→ 733,740 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+209,095→ 209,095 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+604,055→ 604,055 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+195,751→ 195,751 total
Conversion
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31+209,095→ 209,095 total
Purchase
ANAPTYSBIO, INC$ANAB
Common Stock
2017-01-31$15.00/sh+311,291→ 311,291 total
Conversion
GLAUKOS Corp$GKOS
Series F Convertible Preferred Stock
2015-06-30−253,390→ 0 total
Conversion
GLAUKOS Corp$GKOS
Series E Convertible Preferred Stock
2015-06-30−151,653→ 0 total
Conversion
GLAUKOS Corp$GKOS
Series D Convertible Preferred Stock
2015-06-30−674,510→ 0 total
Conversion
GLAUKOS Corp$GKOS
Common Stock
2015-06-30+2,603,362→ 2,603,362 total
Conversion
GLAUKOS Corp$GKOS
Series C Convertible Preferred Stock
2015-06-30−1,523,809→ 0 total
Exercise of In-Money
GLAUKOS Corp$GKOS
Series D Convertible Preferred Stock Warrant (right to buy)
2015-06-26−24,705→ 0 total
Exercise of In-Money
GLAUKOS Corp$GKOS
Series D Convertible Preferred Stock
2015-06-26$7.65/sh+24,705→ 674,510 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Series D Convertible Stock
2015-05-12−3,676,078→ 0 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+582,490→ 582,490 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+222,231→ 804,721 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+392,113→ 1,196,834 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12+540,498→ 1,737,332 total
Purchase
COLLEGIUM PHARMACEUTICAL, INC$COLL
Common Stock
2015-05-12$12.00/sh+150,000→ 1,887,332 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Series A Convertible Stock
2015-05-12−4,019,183→ 0 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Series B Convertible Stock
2015-05-12−1,533,399→ 0 total
Conversion
COLLEGIUM PHARMACEUTICAL, INC$COLL
Series C Convertible Stock
2015-05-12−2,705,585→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
stock option (right to buy)
2014-03-19$4.75/sh−12,500→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
stock option (right to buy)
2014-03-19$7.65/sh−12,500→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
stock option (right to buy)
2014-03-19$11.02/sh−17,500→ 0 total
Disposition to Issuer
CADENCE PHARMACEUTICALS INC
stock option (right to buy)
2014-03-19$6.79/sh−25,000→ 0 total

Companies

Recent Filings

Address

C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200

SAN DIEGO, CA, 92130

View on SEC.gov